TarThera, Inc. develops advanced internet-based database solutions for drug development and biotechnology. The company provides consulting solutions for companies involved in preclinical and clinical development of cancer therapies. CuraBase (R), TarThera's lead product, is a novel integrated oncology database containing information on novel therapeutics, molecular targets, and related cancer biology. The TarThera consulting service, integrates renowned experts and the CuraBase Database using embedded online collaboration tools to efficiently provide strategic advice on development of drugs and diagnostics, target identification and validation, and promising research directions. CuraBase was developed through collaboration of university-based cancer researchers/physicians with long-term experience in this field, and developers of secure Internet technology .
| Website | http://www.curabase.com |
| Revenue | $1 million |
| Employees | 2 (1 on RocketReach) |
| Founded | 2004 |
| Address | 301 Ashton Lane, Mill Valley, California 94941, US |
| Phone | +1 415-891-8206 |
| Industry | Biotechnology, Real Estate, Information technology, Cancer Drug Development |
| Keywords | Pharmaceutical Database, Biotechnology Consulting, Data Management Solutions, Preclinical Consulting, Clinical Trial Consulting, Biotech Consulting Services, Pharmaceutical Consulting |
| Competitors | Novartis, Merck & Co., Inc., Sanofi, AstraZeneca, Bristol Myers Squibb, Genentech, Amgen, Regeneron, Gilead Sciences, Kronos Bio +44 more (view full list) |
| SIC | SIC Code 653 Companies, SIC Code 65 Companies |
| NAICS | NAICS Code 531 Companies, NAICS Code 5313 Companies, NAICS Code 53132 Companies, NAICS Code 53 Companies |
Looking for a particular TarThera, Inc employee's phone or email?
The TarThera, Inc annual revenue was $1 million in 2026.
John Zorn is the CFO of TarThera, Inc.
1 people are employed at TarThera, Inc.
TarThera, Inc is based in Mill Valley, California.
The NAICS codes for TarThera, Inc are [531, 5313, 53132, 53].
The SIC codes for TarThera, Inc are [653, 65].